Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018

Curetis / Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018

Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germany, September 17, 2018, 01:00 a.m. EST -- Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that the Company is scheduled to attend the following industry and investor conferences in the fourth quarter of 2018.

October:

Cantor Fitzgerald Healthcare Conference, October 01-03, 2018 - New York City, NY, USA: one-on-one meetings and company presentation.

Ladenburg Thalmann 2018 Healthcare Conference, October 02, 2018 - New York City, NY, USA: one-on-one meetings and company presentation.

ID Week - Infectious Disease, October 04-06, 2018 - San Francisco, CA, USA: Moscone Center: booth 201.

Large & Midcap Event, October 08-09, 2018 - Paris, France: one-on-one meetings and company presentation.

Family Office Day, October 17, 2018 - Vienna, Austria: one-on-one meetings and company presentation.

DKOU 2018, October 23-26, 2018 - Berlin, Germany: Messe Berlin, booth 89, hall 2.2.

SCASM 2018 Southern California Branch of the American Society for Microbiology,
October 29-30, 2018 - San Diego, CA, USA: Hyatt Regency La Jolla, booth.

November:

AMP - Molecular Biology, November 01-03, 2018 - San Antonio, TX, USA: San Antonio Convention Center, booth 1512.

SEACM, November 09-10, 2018 - Charlotte, NC, USA: Sheraton Airport Charlotte, booth.

December:

ASHP - Hospital Pharmacists, December 03-07, 2018 - Anaheim, CA, USA: Anaheim Convention Center, booth 879.

DIVI 2018, December 05-07, 2018 - Leipzig, Germany: Congress Center Leipzig, booth H12.

RICAI 2018, December 17-18, 2018 - Paris, France: Palais de Congrès de Paris, booth 3.

###

About Curetis

Curetis N.V.'s (Euronext: CURE) goal is to become a leading provider of innovative solutions for molecular microbiology diagnostics designed to address the global challenge of diagnosing severe infectious diseases and identifying antibiotic resistances in hospitalized patients.